4.3 Article

Mesenchymal stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

Antonio Uccelli et al.

Summary: The MESEMS study aimed to evaluate the safety and activity of autologous bone marrow-derived MSCs in patients with active multiple sclerosis. The results showed that MSC treatment did not affect GELs and does not support its use in treating multiple sclerosis.

LANCET NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice

Xiao-Yu Zheng et al.

NEUROCHEMICAL RESEARCH (2017)

Article Cell & Tissue Engineering

Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury

Daniel J. Kota et al.

STEM CELLS TRANSLATIONAL MEDICINE (2016)

Review Clinical Neurology

Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

Gavin Giovannoni et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)

Article Biochemistry & Molecular Biology

Grey matter lesions in MS From histology to clinical implications

Massimiliano Calabrese et al.

Article Cell & Tissue Engineering

Mesenchymal Stem Cells

Dah-Ching Ding et al.

CELL TRANSPLANTATION (2011)

Article Clinical Neurology

Cognitive impairment in multiple sclerosis

Stefanie Hoffmann et al.

CURRENT OPINION IN NEUROLOGY (2007)